| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Shibata A et al. | Genetic polymorphisms in the androgen receptor and type II 5 alpha-reductase genes in prostate enlargement. | 2001 | J. Urol. | pmid:11547131 |
| Helfand BT et al. | Consequences of switching 5alpha-reductase inhibitors on prostate specific antigen velocity. | 2010 | J. Urol. | pmid:20483154 |
| Elterman DS et al. | Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors. | 2010 | J. Urol. | pmid:20303529 |
| Droller MJ | A guideline for discussion and some thoughts. | 2009 | J. Urol. | pmid:19249064 |
| Kramer BS et al. | Use of 5alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline. | 2009 | J. Urol. | pmid:19249063 |
| Hadziselimovic F and Dessouky N | Differences in testicular development between 5alpha-reductase 2 deficiency and isolated bilateral cryptorchidism. | 2008 | J. Urol. | pmid:18639287 |
| Lunacek A et al. | Fetal distribution of 5alpha-reductase 1 and 5alpha-reductase 2, and their input on human prostate development. | 2007 | J. Urol. | pmid:17574609 |
| Kibel AS | Optimizing prostate biopsy techniques. | 2007 | J. Urol. | pmid:17509275 |
| Morgentaler A | Re: The interpretation of serum prostate specific antigen in men receiving 5alpha-reductase inhibitors: a review and clinical recommendations. | 2007 | J. Urol. | pmid:17437855 |
| Andriole G et al. | The effects of 5alpha-reductase inhibitors on the natural history, detection and grading of prostate cancer: current state of knowledge. | 2005 | J. Urol. | pmid:16280736 |
| Li Z et al. | Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population. | 2003 | J. Urol. | pmid:12771801 |
| Plemenitas A et al. | Identification of progesterone binding sites in the plasma membrane of the filamentous fungus Cochliobolus lunatus. | 1993 | J. Steroid Biochem. Mol. Biol. | pmid:8499335 |
| Wiebe JP et al. | The role of progesterone metabolites in breast cancer: potential for new diagnostics and therapeutics. | 2005 | J. Steroid Biochem. Mol. Biol. | pmid:15860263 |
| Raynaud JP et al. | Inhibition of type 1 and type 2 5alpha-reductase activity by free fatty acids, active ingredients of Permixon. | 2002 | J. Steroid Biochem. Mol. Biol. | pmid:12477490 |
| Jang S et al. | Establishment of type II 5alpha-reductase over-expressing cell line as an inhibitor screening model. | J. Steroid Biochem. Mol. Biol. | pmid:17646096 | |
| Dalla Valle L et al. | Expression of cytochrome P450c17 and other steroid-converting enzymes in the rat kidney throughout the life-span. | 2004 | J. Steroid Biochem. Mol. Biol. | pmid:15261307 |
| Reichert W et al. | Stable expression of human 5alpha-reductase type II in COS1 cells due to chromosomal gene integration: a novel tool for inhibitor identification. | 2001 | J. Steroid Biochem. Mol. Biol. | pmid:11595508 |
| Zhou X et al. | High abundance of testosterone and salivary androgen-binding protein in the lateral nasal gland of male mice. | 2009 | J. Steroid Biochem. Mol. Biol. | pmid:19524040 |
| Rosati F et al. | 5alpha-Reductase activity in Lycopersicon esculentum: cloning and functional characterization of LeDET2 and evidence of the presence of two isoenzymes. | 2005 | J. Steroid Biochem. Mol. Biol. | pmid:15993049 |
| Luu-The V et al. | Quantitative appreciation of steroidogenic gene expression in mouse tissues: new roles for type 2 5alpha-reductase, 20alpha-hydroxysteroid dehydrogenase and estrogen sulfotransferase. | 2005 | J. Steroid Biochem. Mol. Biol. | pmid:15860270 |
| McVey MJ et al. | Altered testicular microsomal steroidogenic enzyme activities in rats with lifetime exposure to soy isoflavones. | 2004 | J. Steroid Biochem. Mol. Biol. | pmid:15698548 |
| Pham H and Ziboh VA | 5 alpha-reductase-catalyzed conversion of testosterone to dihydrotestosterone is increased in prostatic adenocarcinoma cells: suppression by 15-lipoxygenase metabolites of gamma-linolenic and eicosapentaenoic acids. | 2002 | J. Steroid Biochem. Mol. Biol. | pmid:12589947 |
| Guzmán DC et al. | Effect of testosterone and steroids homologues on indolamines and lipid peroxidation in rat brain. | 2005 | J. Steroid Biochem. Mol. Biol. | pmid:15857756 |
| Chen CL et al. | Cholest-4-en-3-one attenuates TGF-β responsiveness by inducing TGF-β receptors degradation in Mv1Lu cells and colorectal adenocarcinoma cells. | 2017 | J. Recept. Signal Transduct. Res. | pmid:27401208 |
| Nguyen PN et al. | Increased allopregnanolone levels in the fetal sheep brain following umbilical cord occlusion. | 2004 | J. Physiol. (Lond.) | pmid:15331682 |
| Bordet T et al. | Specific antinociceptive activity of cholest-4-en-3-one, oxime (TRO19622) in experimental models of painful diabetic and chemotherapy-induced neuropathy. | 2008 | J. Pharmacol. Exp. Ther. | pmid:18492948 |
| Bordet T et al. | Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis. | 2007 | J. Pharmacol. Exp. Ther. | pmid:17496168 |
| DellaGreca M et al. | Solid-state photodimerization of cholest-4-en-3-one. | 2001 | J. Org. Chem. | pmid:11300900 |
| Patel S and Mishra BK | Oxidation of cholesterol by a biomimetic oxidant, cetyltrimethylammonium dichromate. | 2006 | J. Org. Chem. | pmid:16626135 |
| Schuster RE and Bennett RD | A direct low temperature 1H and 19F nuclear magnetic resonance study of boron trifluoride complexes with 4-cholesten-3-one, 1(5beta)-androstene-3,17-dione, 5beta-androstane-3,17-dione, and obacunone. | 1973 | J. Org. Chem. | pmid:4733449 |
| Johnson DC and Widlanski TS | Cerium(III) chloride-mediated reactions of sulfonamide dianions. | 2003 | J. Org. Chem. | pmid:12816492 |
| Abbiati G et al. | Sequential amination/annulation/aromatization reaction of carbonyl compounds and propargylamine: a new one-pot approach to functionalized pyridines. | 2003 | J. Org. Chem. | pmid:12946136 |
| Suzuki K | Anti-obesity effect of cholest-4-en-3-one, an intestinal catabolite of cholesterol, on mice. | 1993 | J. Nutr. Sci. Vitaminol. | pmid:8120678 |
| Luchetti S et al. | Comparative non-radioactive RT-PCR assay: an approach to study the neurosteroids biosynthetic pathway in humans. | 2006 | J. Neurosci. Methods | pmid:16378642 |
| Martin LJ et al. | The mitochondrial permeability transition pore regulates nitric oxide-mediated apoptosis of neurons induced by target deprivation. | 2011 | J. Neurosci. | pmid:21209222 |
| Paris JJ et al. | Inhibition of 5α-reductase activity in late pregnancy decreases gestational length and fecundity and impairs object memory and central progestogen milieu of juvenile rat offspring. | 2011 | J. Neuroendocrinol. | pmid:21914008 |
| Riters LV et al. | Seasonal variation in androgen-metabolizing enzymes in the diencephalon and telencephalon of the male European starling (Sturnus vulgaris). | 2001 | J. Neuroendocrinol. | pmid:11737557 |
| Soma KK et al. | Brain aromatase, 5 alpha-reductase, and 5 beta-reductase change seasonally in wild male song sparrows: relationship to aggressive and sexual behavior. | 2003 | J. Neurobiol. | pmid:12884261 |
| Sung YM et al. | Re: Hormonal markers and hepatitis B virus-related hepatocellular carcinoma risk: a nested case-control study among men. | 2003 | J. Natl. Cancer Inst. | pmid:12671025 |
| Moinpour CM et al. | Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial. | 2007 | J. Natl. Cancer Inst. | pmid:17596576 |
| Faragalla J et al. | Comparative pharmacophore development for inhibitors of human and rat 5-alpha-reductase. | 2003 | J. Mol. Graph. Model. | pmid:12798393 |
| Aissaoui A et al. | Novel cationic lipids incorporating an acid-sensitive acylhydrazone linker: synthesis and transfection properties. | 2004 | J. Med. Chem. | pmid:15456264 |
| Gallo LL et al. | Enzymatic assay for cholesterol ester hydrolase activity. | 1978 | J. Lipid Res. | pmid:712250 |
| Aringer L | 7-Hydroxylation of 3-oxygenated C27-, C28-, and C29-steroids in rat liver 18,000 g supernate. | 1978 | J. Lipid Res. | pmid:731128 |
| Norlin M et al. | On the substrate specificity of human CYP27A1: implications for bile acid and cholestanol formation. | 2003 | J. Lipid Res. | pmid:12777473 |
| Le Lay S et al. | Caveolin-1-dependent and -independent membrane domains. | 2009 | J. Lipid Res. | pmid:19074371 |
| Contreras JA et al. | Combination of an enzymatic method and HPLC for the quantitation of cholesterol in cultured cells. | 1992 | J. Lipid Res. | pmid:1512516 |
| Wakisaka N et al. | Effectiveness of finasteride on patients with male pattern baldness who have different androgen receptor gene polymorphism. | 2005 | J. Investig. Dermatol. Symp. Proc. | pmid:16382684 |
| Shapiro J and Kaufman KD | Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss). | 2003 | J. Investig. Dermatol. Symp. Proc. | pmid:12894990 |
| Fritsch M et al. | Sebocytes are the key regulators of androgen homeostasis in human skin. | 2001 | J. Invest. Dermatol. | pmid:11348472 |
| Haeffner F et al. | Model studies of cholesterol and ascorbate oxidation by copper complexes: relevance to Alzheimer's disease beta-amyloid metallochemistry. | 2005 | J. Inorg. Biochem. | pmid:16271394 |
| Ellis JA et al. | Androgenic correlates of genetic variation in the gene encoding 5alpha-reductase type 1. | 2005 | J. Hum. Genet. | pmid:16155734 |
| Gonzales E et al. | SRD5B1 (AKR1D1) gene analysis in delta(4)-3-oxosteroid 5beta-reductase deficiency: evidence for primary genetic defect. | 2004 | J. Hepatol. | pmid:15030995 |
| Ueki I et al. | SRD5B1 gene analysis needed for the accurate diagnosis of primary 3-oxo-Delta4-steroid 5beta-reductase deficiency. | 2009 | J. Gastroenterol. Hepatol. | pmid:19175828 |
| Joo SH et al. | Biosynthesis of a cholesterol-derived brassinosteroid, 28-norcastasterone, in Arabidopsis thaliana. | 2012 | J. Exp. Bot. | pmid:22170941 |
| Weber KS et al. | Dietary soy-phytoestrogens decrease testosterone levels and prostate weight without altering LH, prostate 5alpha-reductase or testicular steroidogenic acute regulatory peptide levels in adult male Sprague-Dawley rats. | 2001 | J. Endocrinol. | pmid:11524239 |
| Lemus AE et al. | Bioconversion of norethisterone, a progesterone receptor agonist into estrogen receptor agonists in osteoblastic cells. | 2009 | J. Endocrinol. | pmid:19008332 |
| Rho SS et al. | The hair growth promoting effect of Asiasari radix extract and its molecular regulation. | 2005 | J. Dermatol. Sci. | pmid:15862941 |
| Li L et al. | Selective induction of apoptosis in the hamster flank sebaceous gland organ by a topical liposome 5-alpha-reductase inhibitor: a treatment strategy for acne. | 2010 | J. Dermatol. | pmid:20175850 |
| Kiyokage E et al. | Localization of 5alpha-reductase in the rat main olfactory bulb. | 2005 | J. Comp. Neurol. | pmid:16261538 |
| Frankel PH and Twardowski P | Guideline for 5-alpha-reductase inhibitors in the prevention of prostate cancer is premature. | 2009 | J. Clin. Oncol. | pmid:19738114 |
| Puglielli L et al. | Alzheimer disease beta-amyloid activity mimics cholesterol oxidase. | 2005 | J. Clin. Invest. | pmid:16127459 |
| Iranmanesh A and Veldhuis JD | Combined inhibition of types I and II 5 alpha-reductase selectively augments the basal (nonpulsatile) mode of testosterone secretion in young men. | 2005 | J. Clin. Endocrinol. Metab. | pmid:15811930 |
| Asada Y et al. | 5 alpha-reductase type 2 is constitutively expressed in the dermal papilla and connective tissue sheath of the hair follicle in vivo but not during culture in vitro. | 2001 | J. Clin. Endocrinol. Metab. | pmid:11397903 |
| Sobel V et al. | Bone mineral density in the complete androgen insensitivity and 5alpha-reductase-2 deficiency syndromes. | 2006 | J. Clin. Endocrinol. Metab. | pmid:16735493 |
| Hammer F et al. | Sex steroid metabolism in human peripheral blood mononuclear cells changes with aging. | 2005 | J. Clin. Endocrinol. Metab. | pmid:16091484 |
| Martin RM et al. | Familial hyperestrogenism in both sexes: clinical, hormonal, and molecular studies of two siblings. | 2003 | J. Clin. Endocrinol. Metab. | pmid:12843139 |
| Silfen ME et al. | 5 alpha-reductase and 11 beta-hydroxysteroid dehydrogenase activity in prepubertal Hispanic girls with premature adrenarche. | 2002 | J. Clin. Endocrinol. Metab. | pmid:12364451 |
| Matthiesson KL et al. | Novel male hormonal contraceptive combinations: the hormonal and spermatogenic effects of testosterone and levonorgestrel combined with a 5alpha-reductase inhibitor or gonadotropin-releasing hormone antagonist. | 2005 | J. Clin. Endocrinol. Metab. | pmid:15509637 |
| Vassiliadi DA et al. | Increased 5 alpha-reductase activity and adrenocortical drive in women with polycystic ovary syndrome. | 2009 | J. Clin. Endocrinol. Metab. | pmid:19567518 |
| Fassnacht M et al. | Beyond adrenal and ovarian androgen generation: Increased peripheral 5 alpha-reductase activity in women with polycystic ovary syndrome. | 2003 | J. Clin. Endocrinol. Metab. | pmid:12788885 |
| Clark RV et al. | Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. | 2004 | J. Clin. Endocrinol. Metab. | pmid:15126539 |
| Veldhuis JD et al. | Aromatase and 5alpha-reductase inhibition during an exogenous testosterone clamp unveils selective sex steroid modulation of somatostatin and growth hormone secretagogue actions in healthy older men. | 2009 | J. Clin. Endocrinol. Metab. | pmid:19088159 |
| Palusinski R and Barud W | Proscar and propecia--a therapeutic perspective. | 2004 | J. Clin. Endocrinol. Metab. | pmid:15579805 |
| Sasaki G et al. | Micropenis and the 5alpha-reductase-2 (SRD5A2) gene: mutation and V89L polymorphism analysis in 81 Japanese patients. | 2003 | J. Clin. Endocrinol. Metab. | pmid:12843198 |
| DeBarber AE et al. | Profiling sterols in cerebrotendinous xanthomatosis: utility of Girard derivatization and high resolution exact mass LC-ESI-MS(n) analysis. | 2011 | J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. | pmid:21168372 |
| Muto A et al. | Detection of Δ4-3-oxo-steroid 5β-reductase deficiency by LC-ESI-MS/MS measurement of urinary bile acids. | 2012 | J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. | pmid:22695323 |
| Gilliver SC et al. | Androgens modulate the inflammatory response during acute wound healing. | 2006 | J. Cell. Sci. | pmid:16449322 |
| Sillat T et al. | Intracrine androgenic apparatus in human bone marrow stromal cells. | 2009 | J. Cell. Mol. Med. | pmid:19298521 |
| Festuccia C et al. | Effects of 5 alpha reductase inhibitors on androgen-dependent human prostatic carcinoma cells. | 2005 | J. Cancer Res. Clin. Oncol. | pmid:15650886 |
| Rojo L et al. | Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease. | 2006 | J. Biomed. Biotechnol. | pmid:17047312 |
| Johnston JB et al. | Functional redundancy of steroid C26-monooxygenase activity in Mycobacterium tuberculosis revealed by biochemical and genetic analyses. | 2010 | J. Biol. Chem. | pmid:20843794 |
| BUCHER NL et al. | Cholesterol biosynthesis in preparations of liver from normal, fasting, x-irradiated, cholesterol-fed, triton, or delta 4-cholesten-3-one-treated rats. | 1959 | J. Biol. Chem. | pmid:13630891 |
| Skrede S and Björkhem I | Biosynthesis of cholestanol from intestinal 7 alpha-hydroxy-4-cholesten-3-one. | 1982 | J. Biol. Chem. | pmid:7045120 |
| Caldinelli L et al. | Dissecting the structural determinants of the stability of cholesterol oxidase containing covalently bound flavin. | 2005 | J. Biol. Chem. | pmid:15817448 |
| McInnes KJ et al. | 5alpha-reduced glucocorticoids, novel endogenous activators of the glucocorticoid receptor. | 2004 | J. Biol. Chem. | pmid:15044432 |
| PUDLES J and BLOCH K | Conversion of 4-hydroxymethylene-Delta 7 cholesten-3-one to cholesterol. | 1960 | J. Biol. Chem. | pmid:13738392 |
| Driscoll MD et al. | Structural and biochemical characterization of Mycobacterium tuberculosis CYP142: evidence for multiple cholesterol 27-hydroxylase activities in a human pathogen. | 2010 | J. Biol. Chem. | pmid:20889498 |
| Lin CW et al. | Substrate uptake and subcellular compartmentation of anoxic cholesterol catabolism in Sterolibacterium denitrificans. | 2015 | J. Biol. Chem. | pmid:25418128 |
| Castro BM et al. | Cholesterol-rich fluid membranes solubilize ceramide domains: implications for the structure and dynamics of mammalian intracellular and plasma membranes. | 2009 | J. Biol. Chem. | pmid:19520848 |
| Capyk JK et al. | Mycobacterial cytochrome p450 125 (cyp125) catalyzes the terminal hydroxylation of c27 steroids. | 2009 | J. Biol. Chem. | pmid:19846551 |
| Liu P et al. | Presence of oxidized cholesterol in caveolae uncouples active platelet-derived growth factor receptors from tyrosine kinase substrates. | 2000 | J. Biol. Chem. | pmid:10918056 |
| Coulombe R et al. | Oxygen access to the active site of cholesterol oxidase through a narrow channel is gated by an Arg-Glu pair. | 2001 | J. Biol. Chem. | pmid:11397813 |
| Papanikolaou A et al. | Cholesterol-dependent lipid assemblies regulate the activity of the ecto-nucleotidase CD39. | 2005 | J. Biol. Chem. | pmid:15890655 |
| Nakagawa Y et al. | Transfer of steroids and alpha-tocopherol between liposomal membranes. | 1980 | J. Biochem. | pmid:6892636 |
| Schmidt LJ et al. | Gene expression in prostate cancer cells treated with the dual 5 alpha-reductase inhibitor dutasteride. | 2004 Nov-Dec | J. Androl. | pmid:15477368 |
| Perlmutter JD and Sachs JN | Inhibiting lateral domain formation in lipid bilayers: simulations of alternative steroid headgroup chemistries. | 2009 | J. Am. Chem. Soc. | pmid:19860442 |
| Leyden J et al. | A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris. | 2004 | J. Am. Acad. Dermatol. | pmid:14988688 |
| Yehuda R et al. | Enduring effects of severe developmental adversity, including nutritional deprivation, on cortisol metabolism in aging Holocaust survivors. | 2009 | J Psychiatr Res | pmid:19162277 |
| Stine KJ et al. | Interaction of the glycoalkaloid tomatine with DMPC and sterol monolayers studied by surface pressure measurements and Brewster angle microscopy. | 2006 | J Phys Chem B | pmid:17078662 |
4-Cholesten-3-one
4-Cholesten-3-one is a lipid of Sterol Lipids (ST) class. 4-cholesten-3-one is associated with abnormalities such as Dehydration, Xanthomatosis, Cerebrotendinous, Peripheral Neuropathy, L.mexicana and Xanthoma. The involved functions are known as CYP27A1activity, 25-hydroxycholesterol 7alpha-hydroxylase activity, Biochemical Pathway, Anabolism and Oxidation. 4-cholesten-3-one often locates in Mitochondria, Liver, Body tissue, Hepatic, Mitochondria and Endothelium of artery. The associated genes with 4-Cholesten-3-one are P4HTM gene, tryptones and Regulon. The related lipids are Cholestenones, 7-hydroxy-4-cholesten-3-one, cholest-4-en-3-one, 25-hydroxycholesterol and 24-hydroxycholesterol.
Cross Reference
Introduction
To understand associated biological information of 4-Cholesten-3-one, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 4-Cholesten-3-one?
4-Cholesten-3-one is suspected in Dehydration, Xanthomatosis, Cerebrotendinous, Peripheral Neuropathy, L.mexicana, Xanthoma, Rare Diseases and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Biochem. J. (1)
- J. Biol. Chem. (1)
- J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (1)
- Others (3)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with 4-Cholesten-3-one
Lipid pathways are not clear in current pathway databases. We organized associated pathways with 4-Cholesten-3-one through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 4-Cholesten-3-one?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- J. Biol. Chem. (2)
- J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (1)
- J. Lipid Res. (1)
- Others (2)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with 4-Cholesten-3-one?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 4-Cholesten-3-one?
Related references are published most in these journals:
- J. Biol. Chem. (2)
- J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (1)
- J. Lipid Res. (1)
- Others (3)
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with 4-Cholesten-3-one?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 4-Cholesten-3-one?
There are no associated biomedical information in the current reference collection.